This article is part of the supplement: Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor
Tumor metastasis to bone
-
* Corresponding author: Jay R Lieberman jlieberman@uchc.edu
Arthritis Research & Therapy 2007, 9(Suppl 1):S5 doi:10.1186/ar2169
Accesses
- Last 30 days: 159 accesses
- Last 365 days: 1374 accesses
- All time: 7522 accesses